Epigenetics Market: By Enzymes (DNA polymerase, Acetylases, DNA ligases, Methyltransferase, RNA ligases, Reverse Transcriptase, Others), By Instruments (Next Generation Sequencers, Mass Spectrometers, Sonicators, qPCRs, Others), By Application (Oncology, Cardiovascular Diseases, Metabolic Diseases, Inflammatory Diseases, Infectious Diseases), By Kits and Assays (Deep Sequencing Kit, Bisulfate Conversion Kit, Methyltransferase Assays, Chip- Seq Kits, Immunoprecipitation Kits, Histone Assay), By End-User (Pharmaceutical and Biotechnological Companies, Contract Research Companies, Academic and Research Institutes), and Geography.  

Purchase Option

$ 4400
$ 6600
$ 8900

Epigenetics Market size was valued at USD 823 million in 2022 and is poised to grow at a CAGR of 13.7% from 2024- 2030. Epigenetics is a study of heritable changes in gene expression which involves the change in phenotype without changing genotype, which in turn affects the reading of genes by cells. Epigenetic changes are natural and regular processes but are also influenced by various factors like lifestyle, environment, age, and state of disease. Epigenetic modifications can manifest a common manner of cells that differentiate terminally to end up as liver cells, skin cells, brain cells, etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer. Systems like histone modification, non-coding RNA-associated gene silencing, and DNA methylation are considered for the initiation of epigenetic change sustainably. In October 2016 Episode an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development.

Epigenetics Market Key Developments:

In June 2011, Cayman chemical company adopted the Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for cayman's new epigenetic screening laboratory.

Global Epigenetics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

13.7%

Largest Market

North America

Fastest Growing Market

North America
Epigenetics Market Dynamics

The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics market. However, high instrument cost and the dearth of skilled personnel are expected to hamper the growth of the market

Global Epigenetics Market Segmentation

By Enzymes
  • DNA polymerase,
  • Acetylases,
  • DNA ligases,
  • Methyltransferase,
  • RNA ligases,
  • Reverse Transcriptase,
  • Others
By Instruments
  • Next Generation Sequencers,
  • Mass Spectrometers,
  • Sonicators,
  • qPCRs,
  • Others
By Application
  • Oncology,
  • Cardiovascular Diseases,
  • Metabolic Diseases,
  • Inflammatory Diseases,
  • Infectious Diseases
By Kits and Assays
  • Deep Sequencing Kit,
  • Bisulfate Conversion Kit,
  • Methyltransferase Assays,
  • Chip- Seq Kits,
  • Immunoprecipitation Kits,
  • Histone Assay
By End User
  • Pharmaceutical and Biotechnological Companies,
  • Contract Research Companies,
  • Academic and Research Institutes

Frequently Asked Questions

The epigenetics market key players are: Illumina, Inc. (U.S.), Abcam plc. (U.K), QIAGEN N.V. (Netherland), New England Biolabs, Inc. (U.S.), Merck & Co. (U.S.), Sigma-Aldrich Corporation (U.S.), Genedata AG(Switzerland), Cayman chemical company (U.S), Active Motif (U.S.), Thermo Fisher Scientific, Inc., (U.S.), Diagenode, Inc. (Belgium), Zymo Research Corporation (U.S.)., Episona Inc. (U.S).

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The epigenetics market size was valued at USD 823 million in 2022

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
1.Executive Summary
2.Global Epigenetics Market Introduction 
2.1.Global Epigenetics Market  - Taxonomy
2.2.Global Epigenetics Market  - Definitions
2.2.1. Enzymes
2.2.2. Instruments
2.2.3.Application
2.2.4.Region
3.Global Epigenetics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Epigenetics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Epigenetics Market  By  Enzymes, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. DNA polymerase,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Acetylases,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. DNA ligases,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Methyltransferase,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. RNA ligases,
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Reverse Transcriptase,
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Others
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
6.Global Epigenetics Market  By  Instruments, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Next Generation Sequencers,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Mass Spectrometers,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Sonicators,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. qPCRs,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.Global Epigenetics Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Oncology,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Cardiovascular Diseases,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Metabolic Diseases,
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Inflammatory Diseases,
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Infectious Diseases
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.Global Epigenetics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Epigenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1.  Enzymes Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.DNA polymerase,
9.1.2.Acetylases,
9.1.3.DNA ligases,
9.1.4.Methyltransferase,
9.1.5.RNA ligases,
9.1.6.Reverse Transcriptase,
9.1.7.Others
9.2.   Instruments Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Next Generation Sequencers,
9.2.2.Mass Spectrometers,
9.2.3.Sonicators,
9.2.4.qPCRs,
9.2.5.Others
9.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Oncology,
9.3.2.Cardiovascular Diseases,
9.3.3.Metabolic Diseases,
9.3.4.Inflammatory Diseases,
9.3.5.Infectious Diseases
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Epigenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1.  Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.DNA polymerase,
10.1.2.Acetylases,
10.1.3.DNA ligases,
10.1.4.Methyltransferase,
10.1.5.RNA ligases,
10.1.6.Reverse Transcriptase,
10.1.7.Others
10.2.   Instruments Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Next Generation Sequencers,
10.2.2.Mass Spectrometers,
10.2.3.Sonicators,
10.2.4.qPCRs,
10.2.5.Others
10.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Oncology,
10.3.2.Cardiovascular Diseases,
10.3.3.Metabolic Diseases,
10.3.4.Inflammatory Diseases,
10.3.5.Infectious Diseases
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Epigenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1.  Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.DNA polymerase,
11.1.2.Acetylases,
11.1.3.DNA ligases,
11.1.4.Methyltransferase,
11.1.5.RNA ligases,
11.1.6.Reverse Transcriptase,
11.1.7.Others
11.2.   Instruments Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Next Generation Sequencers,
11.2.2.Mass Spectrometers,
11.2.3.Sonicators,
11.2.4.qPCRs,
11.2.5.Others
11.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Oncology,
11.3.2.Cardiovascular Diseases,
11.3.3.Metabolic Diseases,
11.3.4.Inflammatory Diseases,
11.3.5.Infectious Diseases
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Epigenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1.  Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.DNA polymerase,
12.1.2.Acetylases,
12.1.3.DNA ligases,
12.1.4.Methyltransferase,
12.1.5.RNA ligases,
12.1.6.Reverse Transcriptase,
12.1.7.Others
12.2.   Instruments Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Next Generation Sequencers,
12.2.2.Mass Spectrometers,
12.2.3.Sonicators,
12.2.4.qPCRs,
12.2.5.Others
12.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Oncology,
12.3.2.Cardiovascular Diseases,
12.3.3.Metabolic Diseases,
12.3.4.Inflammatory Diseases,
12.3.5.Infectious Diseases
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Epigenetics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1.  Enzymes Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.DNA polymerase,
13.1.2.Acetylases,
13.1.3.DNA ligases,
13.1.4.Methyltransferase,
13.1.5.RNA ligases,
13.1.6.Reverse Transcriptase,
13.1.7.Others
13.2.   Instruments Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Next Generation Sequencers,
13.2.2.Mass Spectrometers,
13.2.3.Sonicators,
13.2.4.qPCRs,
13.2.5.Others
13.3.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Oncology,
13.3.2.Cardiovascular Diseases,
13.3.3.Metabolic Diseases,
13.3.4.Inflammatory Diseases,
13.3.5.Infectious Diseases
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Illumina, Inc. (U.S.)
14.2.2.Abcam plc. (U.K)
14.2.3.QIAGEN N.V. (Netherland)
14.2.4.New England Biolabs, Inc. (U.S.)
14.2.5.Merck & Co. (U.S.)
14.2.6.Sigma-Aldrich Corporation (U.S.)
14.2.7.Genedata AG(Switzerland)
14.2.8.Cayman chemical company (U.S)
14.2.9.Active Motif (U.S.)
14.2.10.Thermo Fisher Scientific, Inc., (U.S.)
14.2.11.Diagenode, Inc. (Belgium)
14.2.12.Zymo Research Corporation (U.S.).
14.2.13.Episona Inc. (U.S
15. Research Methodology 
16. Appendix and Abbreviations 
  • Illumina, Inc. (U.S.)
  • Abcam plc. (U.K)
  • QIAGEN N.V. (Netherland)
  • New England Biolabs, Inc. (U.S.)
  • Merck & Co. (U.S.)
  • Sigma-Aldrich Corporation (U.S.)
  • Genedata AG(Switzerland)
  • Cayman chemical company (U.S)
  • Active Motif (U.S.)
  • Thermo Fisher Scientific, Inc., (U.S.)
  • Diagenode, Inc. (Belgium)
  • Zymo Research Corporation (U.S.).
  • Episona Inc. (U.S).

Adjacent Markets